key considerations for mutation detection in cll
Published 7 years ago • 191 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
5:37
precision medicine and mutation detection advances in cll
-
2:55
a model including cd49d expression to predict outcomes in patients with cll treated with ibrutinib
-
3:09
overcoming challenges with targeted therapies for cll: high-risk mutations and btki resistance
-
0:45
key trials in cll and designing a concept for treatment
-
2:49
assessing parameters and standardising biomarker detection in cll
-
5:40
recommendations for biomarker analysis in cll: updates from eric 2024
-
1:33
key factors affecting treatment decision making in cll
-
23:23
identifying and treating high-risk patients in 2023
-
36:35
linc 2023 - treatment of clti: new horizons with novel dcb technology
-
5:24
how long can i live with cll? (chronic lymphocytic leukemia) | the patient story
-
2:14
a new classification for identifying high-risk myeloma based on cytogenetic abnormalities
-
1:04
defining high-risk cll: known and emerging mutations
-
1:39
the importance of diagnostic testing in cll
-
1:28
genomic testing in cll
-
2:11
genetic testing to risk stratify a patient with cll and aid in treatment decisions
-
2:17
a study investigating outcomes for a rare subgroup of cll with cns involvement
-
6:54
biomarker-guided treatment of cll in the chemo-free era
-
2:18
tools to improve the outcomes of patients with cll affected by covid-19
-
1:25
genomic testing and therapeutic decisions in routine clinical practice in cll
-
0:36
the use of ai for analyzing genetic and molecular data in cll
-
2:06
effects of dose adjustment of first-line ibrutinib on real-world dosing patterns and outcomes in cll
-
0:53
all-cll: an ngs panel for molecular characterization of cll